Insider Transactions in Q2 2025 at Nuvectis Pharma, Inc. (NVCT)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 20
2025
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,603
+0.19%
|
$39,221
$7.99 P/Share
|
|
Jun 18
2025
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
28,043
+0.93%
|
$224,344
$8.05 P/Share
|
|
Jun 17
2025
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,399
+0.18%
|
$43,192
$8.11 P/Share
|
|
Jun 12
2025
|
Kenneth Hoberman Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+18.39%
|
-
|
|
Jun 12
2025
|
James F Oliviero Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+25.46%
|
-
|
|
Jun 12
2025
|
Matthew L. Kaplan Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+20.87%
|
-
|
|
May 12
2025
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
21,167
+0.71%
|
$169,336
$8.11 P/Share
|
|
May 08
2025
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,650
+0.02%
|
$21,200
$8.65 P/Share
|
|
May 07
2025
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
12,317
+0.21%
|
$98,536
$8.52 P/Share
|
|
May 06
2025
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
12,444
+0.21%
|
$99,552
$8.52 P/Share
|